Conclusions
RECRUITMENT, GCA
The planned recruitment of this study was not achieved, as it was stopped early by the sponsor due to slow recruitment and the COVID-19 pandemic. Therefore, it is difficult to draw clear conclusions regarding the efficacy of sarilumab in GCA.